Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Former Goldman Sachs employee Fabrice Tourre hasn’t had a great year. In August, a federal jury found him “liable on six of seven claims that he violated federal securities law by intentionally misleading investors,” in addition to “aiding and abetting an alleged fraud by Goldman.” In March, a judge ordered to pay $825,000 ($175,463 in gains related to the deal that investors were misled on, $650,000 in civil penalties). That same month, the University of Chicago, the place that Fab fled to after leaving Goldman Sachs to rebuild his life as an academic, decided it didn’t want him teaching it undergrads. So, things have been tough. But while he may not have the support of his ex-employer, the securities industry, Judge Katherine Forrest, or 100% of Chicago’s economics department faculty,1 he does have this:
And that’s enough to sustain him through at least the Fall ’14 semester.